Further proteins that defined the plasma protein signature of MM in our study were the previously described decreased levels of complement proteins C1q, C1r, and C1s as well as upregulated TGFBI, CFD, and MGP and downregulated CBPN (Figure S2). This evidence concerns the gene VTN and Miyoshi myopathy.